Connected health

Parks Associates: 27 Million Broadband Households Were Unable to Visit a Doctor in 2021, Down Slightly From 2020

Retrieved on: 
Wednesday, October 13, 2021

DALLAS, Oct. 13, 2021 /PRNewswire/ --New research from Parks Associates reveals 27 million US broadband households reported being unable to visit a doctor in 2021, down slightly from 2020.

Key Points: 
  • DALLAS, Oct. 13, 2021 /PRNewswire/ --New research from Parks Associates reveals 27 million US broadband households reported being unable to visit a doctor in 2021, down slightly from 2020.
  • "The pandemic continues to impact consumers' lives, limiting socialization, travel, commerce, and access to healthcare," said Jennifer Kent , VP, Research, Parks Associates.
  • In the first half of 2021, slightly fewer households reported they were unable to see their doctor, compared to 2020, but still with over 27 million households unable to see their care provider as desired, that creates a huge gap that telehealth services can fill."
  • The research reports as of April 2021, 64% of US broadband households used a telehealth service in the prior 12 months.

Sweetch Adds Global Digital and Remote Health Trailblazer Prof. Joseph Kvedar as New Advisory Board Member

Retrieved on: 
Tuesday, October 12, 2021

TEL AVIV, Israel, Oct. 12, 2021 /PRNewswire/ -- Sweetch, a digital therapeutics innovator and creator of the hyper-personalized engagement platform for chronic conditions, announced today that Prof. Joseph Kvedar has joined its advisory board. Prof. Kvedar brings a deep understanding of remote health, digital therapeutics, and reimbursement to Sweetch, and will focus on accelerating the commercial rollout and demonstrated positive clinical impact of the company's hyper-personalized platform, as well as building connections with strategic partners to further the company's success.

Key Points: 
  • TEL AVIV, Israel, Oct. 12, 2021 /PRNewswire/ -- Sweetch , a digital therapeutics innovator and creator of the hyper-personalized engagement platform for chronic conditions, announced today that Prof. Joseph Kvedar has joined its advisory board.
  • "During my almost 30 years of working in connected health innovation, few platforms or devices have excited me or shown as much promise in significantly impacting chronic disease management as Sweetch," said Prof. Joe Kvedar.
  • I am proud to be playing a role at Sweetch during this crucial time of its growth."
  • "Prof. Kvedar is a valuable addition to Sweetch's advisory board as we anticipate upcoming key milestones and the next stage of our company's growth," said Yoni Nevo, CEO of Sweetch.

b.well Connected Health Joins New AWS Program Aimed at Solving Healthcare's Biggest Challenges Through Innovation in the Cloud

Retrieved on: 
Monday, October 11, 2021

Unlike a typical startup accelerator, the AWS Healthcare Accelerator is designed to accelerate growth in the cloud for companies that already have an established product-market fit, an existing customer base and significant revenue.

Key Points: 
  • Unlike a typical startup accelerator, the AWS Healthcare Accelerator is designed to accelerate growth in the cloud for companies that already have an established product-market fit, an existing customer base and significant revenue.
  • The four-week program will prepare the cohort companies to be matched for collaboration opportunities with AWS healthcare customers and members of the AWS Partner Network seeking innovative healthcare solutions to speed their digital transformation.
  • "Consumers are desperate to find a way to simplify and take control of their disconnected and complex healthcare experience," Valdes continued.
  • Valdes will provide a presentation, "The Future of Health is Collaborative," at the HLTH 2021 conference in Boston on Tuesday, October 19th.

A $598.8 Million Global Opportunity for Fog Computing by 2026 - New Research from StrategyR

Retrieved on: 
Friday, October 8, 2021

SAN FRANCISCO, Oct. 8, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Fog Computing - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, Oct. 8, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Fog Computing - Global Market Trajectory & Analytics" .
  • Preview Registry
    Amid the COVID-19 crisis, the global market for Fog Computing estimated at US$52.1 Million in the year 2020, is projected to reach a revised size of US$598.8 Million by 2026, growing at a CAGR of 49.5% over the analysis period.
  • The U.S. Market is Estimated at $25.3 Million in 2021, While China is Forecast to Reach $99 Million by 2026
    The Fog Computing market in the U.S. is estimated at US$25.3 Million in the year 2021.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

The PharmaKon Brings New Access, Diversity to Clinical Trials Through its Allied Approach to Meeting Patients Where They Are

Retrieved on: 
Wednesday, October 6, 2021

Three nursing specialties are being used by The PharmaKon to staff its clinical trials: virtual nurses, remote mobile nurses, and patient concierges.

Key Points: 
  • Three nursing specialties are being used by The PharmaKon to staff its clinical trials: virtual nurses, remote mobile nurses, and patient concierges.
  • Over the last two decades few changes have been made to ensure inclusion and diversity in clinical trials, adds Curtis Wilson, VP Clinical Operations at The PharmaKon.
  • Clinical trials are now available to patients who otherwise would not be able to participate in studies.
  • Rural and marginalized communities, LGBTQ, people of color and low-income patients now have an equal opportunity to take part in innovative clinical trials.

Flexiti Launches 0% Interest Financing at 78 London Drugs Locations

Retrieved on: 
Tuesday, September 28, 2021

Flexiti Financial Inc. (Flexiti), a leading provider of buy now, pay later point-of-sale consumer financing solutions for retailers, announced today it has launched its 0% interest1 financing solution at London Drugs.

Key Points: 
  • Flexiti Financial Inc. (Flexiti), a leading provider of buy now, pay later point-of-sale consumer financing solutions for retailers, announced today it has launched its 0% interest1 financing solution at London Drugs.
  • Through Flexitis omni-channel solution, customers can apply for a FlexitiCard in-store at 78 London Drugs locations.
  • With Flexitis financing, London Drugs customers can get access to 0% interest1 financing to purchase a variety of products.
  • With 78 retail locations across Western Canada, we are thrilled to be adding London Drugs to our network.

b.well Connected Health Adds Industry Veterans in Key Roles

Retrieved on: 
Tuesday, September 14, 2021

BALTIMORE, Sept. 14, 2021 /PRNewswire/ -- b.well Connected Health , the digital transformation platform providing consumers a new front end to health care, today announced adding key executives to its marketing and sales organization.

Key Points: 
  • BALTIMORE, Sept. 14, 2021 /PRNewswire/ -- b.well Connected Health , the digital transformation platform providing consumers a new front end to health care, today announced adding key executives to its marketing and sales organization.
  • Romy Carlsonhas joined b.well Connected Health as Vice President Partnerships.
  • Carlson brings over 20 years of partnership strategy, enterprise health and sales experience with leading healthcare organizations.
  • b.well Connected Health is a healthcare technology company providing platform services comprised of five core capabilities that work together to enable health systems, payers, and employers with a configurable and personalized digital health experience for their populations.

Zimmer Biomet Announces New Data Supporting Clinical Benefits of mymobility® with Apple Watch® at AAOS 2021

Retrieved on: 
Tuesday, August 31, 2021

mymobility with Apple Watch is a part of ZBEdge , Zimmer Biomet's suite of connected digital and robotic technologies designed to deliver actionable insights with the goal of improving patient outcomes.

Key Points: 
  • mymobility with Apple Watch is a part of ZBEdge , Zimmer Biomet's suite of connected digital and robotic technologies designed to deliver actionable insights with the goal of improving patient outcomes.
  • The data are being presented at the American Academy of Orthopaedic Surgeons (AAOS) 2021 Annual Meeting being held on August 31 to September 3 in San Diego.
  • "The introduction of mymobility with Apple Watch underscores Zimmer Biomet's commitment to evaluating the real-world clinical benefits of a remote care management platform after orthopedic surgery," said Robert Kraal, Vice President and General Manager, Connected Health at Zimmer Biomet.
  • Apple Watch and iPhone are trademarks of Apple, Inc., registered in the US and other countries.

Parks Associates: 55% of US Broadband Households own a Connected Health Device, a 30% Increase From 42% in 2020

Retrieved on: 
Tuesday, August 31, 2021

Parks Associates' research reveals 55% of US broadband households own at least one connected health device, such as a smart watch or pulse oximeter.

Key Points: 
  • Parks Associates' research reveals 55% of US broadband households own at least one connected health device, such as a smart watch or pulse oximeter.
  • The executive event, sponsored by Alarm.com, Essence, and Everise, features virtual sessions highlighting consumer data and industry insights examining connected solutions in digital health.
  • "The connected health industry will see tremendous innovation and the proper momentum it deserves over the next few years," Locke said.
  • Connected Health Summitis focused on the impact of connected devices and IoT healthcare solutions on consumers.

Parks Associates: 73% of US Caregivers Likely to Buy an Independent Living Solution for their Loved One

Retrieved on: 
Monday, August 30, 2021

DALLAS, Aug. 30, 2021 /PRNewswire/ --New connected health research from Parks Associates finds 73% of current caregivers are likely to buy an independent living solution for their loved one.

Key Points: 
  • DALLAS, Aug. 30, 2021 /PRNewswire/ --New connected health research from Parks Associates finds 73% of current caregivers are likely to buy an independent living solution for their loved one.
  • Among these intenders, 28% are planning to acquire a smart watch, 25% a PERS solution, 25% a professionally installed home sensor system, and 22% a smart speaker/display solution.
  • and as the founder of Heal and HeyRenee, I am privileged to play an important role in bridging the health divide."
  • Connected Health Summit is a virtual executive conference focused on the impact of connected devices and IoT healthcare solutions on consumers at home.